(FGEN) FibroGen - Performance -68.9% in 12m
FGEN performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-83.74%
#149 in Peer-Group
Rel. Strength
4.93%
#7297 in Stock-Universe
Total Return 12m
-68.90%
#160 in Peer-Group
Total Return 5y
-99.48%
#188 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 61.4 |
| High / Low | USD |
|---|---|
| 52 Week High | 31.50 USD |
| 52 Week Low | 5.16 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 40.40 |
| Buy/Sell Signal +-5 | 0.74 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: FGEN (-68.9%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: FGEN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for FGEN
| Total Return (including Dividends) | FGEN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -26.45% | 3.36% | 5.25% |
| 3 Months | -19.86% | 15.73% | 24.13% |
| 12 Months | -68.90% | -7.02% | 14.15% |
| 5 Years | -99.48% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | FGEN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -82.7% | 4.4% | 81% |
| 3 Months | -30.7% | 78.8% | 96.9% |
| 12 Months | -60% | -85.8% | 44.9% |
| 5 Years | -87.8% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th5.00 | -28.84% | -30.12% |
| 3 Month | %th13.00 | -30.75% | -35.44% |
| 12 Month | %th20.00 | -66.55% | -72.76% |
| 5 Years | %th6.00 | -99.31% | -99.75% |
FAQs
Does FibroGen (FGEN) outperform the market?
No,
over the last 12 months FGEN made -68.90%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months FGEN made -19.86%, while XBI made 15.73%.
Performance Comparison FGEN vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
FGEN vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 5.8% | -31.7% | -72% | -83% |
| US NASDAQ 100 | QQQ | 6% | -31.8% | -72.7% | -82% |
| German DAX 40 | DAX | 7.9% | -25% | -84.2% | -98% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 5.9% | -29.7% | -75.4% | -89% |
| Hongkong Hang Seng | HSI | 6.2% | -32.5% | -91.5% | -107% |
| India NIFTY 50 | INDA | 7.6% | -29.9% | -72.3% | -68% |
| Brasil Bovespa | EWZ | 3.3% | -35.3% | -97.1% | -79% |
FGEN vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 7.1% | -32.4% | -76.2% | -93% |
| Consumer Discretionary | XLY | 6.3% | -29.6% | -64.4% | -87% |
| Consumer Staples | XLP | 5.5% | -27.1% | -73.7% | -78% |
| Energy | XLE | 5.4% | -33.5% | -67.9% | -69% |
| Financial | XLF | 5.1% | -31.5% | -76.9% | -99% |
| Health Care | XLV | 6.3% | -28.6% | -64.7% | -64% |
| Industrial | XLI | 5.7% | -30.7% | -79.9% | -94% |
| Materials | XLB | 3.5% | -30.7% | -76.5% | -75% |
| Real Estate | XLRE | 5.8% | -27.4% | -71.7% | -82% |
| Technology | XLK | 5% | -35.1% | -74.4% | -80% |
| Utilities | XLU | 6.8% | -28.2% | -75.3% | -92% |
| Aerospace & Defense | XAR | 7.9% | -33.5% | -90.6% | -118% |
| Biotech | XBI | 4.8% | -29.8% | -58.8% | -62% |
| Homebuilder | XHB | 3.3% | -33.5% | -64.9% | -74% |
| Retail | XRT | 3.2% | -31.4% | -67.7% | -80% |
FGEN vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 4.9% | -34.9% | -63.6% | -61% |
| Natural Gas | UNG | 15.3% | -16.6% | -55.2% | -67% |
| Gold | GLD | 5.5% | -25.2% | -92.7% | -108% |
| Silver | SLV | 4.7% | -33.4% | -89.4% | -87% |
| Copper | CPER | 6.7% | -31% | -89.1% | -80% |
FGEN vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 7.6% | -27.5% | -68.6% | -67% |
| iShares High Yield Corp. Bond | HYG | 7% | -28.1% | -70.9% | -79% |